Cathepsin Z Protein

Cathepsin Z Protein

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4ea;"><b>Cathepsin Z Protein</b></th></tr>
<tr><td><b>Gene</b></td><td>[CTSZ](/genes/ctsz)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[Q9UBR2](https://www.uniprot.org/uniprot/Q9UBR2)</td></tr>
<tr><td><b>PDB Structures</b></td><td>1DEU, 1FV7, 4CSO</td></tr>
<tr><td><b>Molecular Weight</b></td><td>~34.6 kDa</td></tr>
<tr><td><b>Subcellular Localization</b></td><td>Lysosomes, extracellular</td></tr>
<tr><td><b>Protein Family</b></td><td>Cathepsin family, cysteine protease</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">3 edges</a></td>
</tr>
</table>
</div>

Overview

Cathepsin Z Protein is a protein. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.

Structure

Cathepsin Z (also known as cathepsin X) is a member of the cathepsin family of cysteine proteases[@sevenich2024]. The protein is synthesized as a preproenzyme with an N-terminal signal peptide, a propeptide, and a mature catalytic domain[@mohamed2023]. Unlike other cathepsins, cathepsin Z contains a unique C-terminal extension with an RGD motif that mediates cell adhesion through integrin binding[@jevnikar2024]. The active site contains the catalytic triad Cys-His-Asn characteristic of papain-like cysteine proteases[@wang2023].

Normal Function in the Nervous System

Cathepsin Z Protein

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4ea;"><b>Cathepsin Z Protein</b></th></tr>
<tr><td><b>Gene</b></td><td>[CTSZ](/genes/ctsz)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[Q9UBR2](https://www.uniprot.org/uniprot/Q9UBR2)</td></tr>
<tr><td><b>PDB Structures</b></td><td>1DEU, 1FV7, 4CSO</td></tr>
<tr><td><b>Molecular Weight</b></td><td>~34.6 kDa</td></tr>
<tr><td><b>Subcellular Localization</b></td><td>Lysosomes, extracellular</td></tr>
<tr><td><b>Protein Family</b></td><td>Cathepsin family, cysteine protease</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">3 edges</a></td>
</tr>
</table>
</div>

Overview

Cathepsin Z Protein is a protein. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.

Structure

Cathepsin Z (also known as cathepsin X) is a member of the cathepsin family of cysteine proteases[@sevenich2024]. The protein is synthesized as a preproenzyme with an N-terminal signal peptide, a propeptide, and a mature catalytic domain[@mohamed2023]. Unlike other cathepsins, cathepsin Z contains a unique C-terminal extension with an RGD motif that mediates cell adhesion through integrin binding[@jevnikar2024]. The active site contains the catalytic triad Cys-His-Asn characteristic of papain-like cysteine proteases[@wang2023].

Normal Function in the Nervous System

Cathepsin Z is expressed in various cell types in the nervous system, including [neurons](/entities/neurons), [astrocytes](/entities/astrocytes), and [microglia](/cell-types/microglia-neuroinflammation)[@sevenich2024]. The enzyme participates in extracellular matrix remodeling, cell migration, and immune responses. In neurons, cathepsin Z may contribute to axonal guidance and synaptic plasticity through its role in extracellular proteolysis[@liao2024]. The protein is also secreted and can function extracellularly, where it may participate in wound healing and immune surveillance[@brix2023].

Role in Neurodegeneration

Alzheimer's Disease

Cathepsin Z is upregulated in AD brain and localizes to amyloid plaques and neurofibrillary tangles[@kinsey2024]. The enzyme contributes to [amyloid-beta](/proteins/amyloid-beta) generation through its ability to process [APP](/entities/app-protein) and may also degrade [tau protein](/proteins/tau)[@gocheva2023]. Cathepsin Z deficiency in mouse models reduces amyloid pathology and improves cognitive function, suggesting a pathogenic role in AD[@joyce2024].

Parkinson's Disease

Cathepsin Z is involved in the processing of [alpha-synuclein](/proteins/alpha-synuclein) and may contribute to its aggregation and toxicity[@vasiljeva2024]. The enzyme is upregulated in PD brain and in models of dopaminergic degeneration. Cathepsin Z also participates in neuroinflammatory responses through its interactions with immune cells[@turk2024].

Amyotrophic Lateral Sclerosis (ALS)

Cathepsin Z is upregulated in ALS spinal cord and participates in the inflammatory response that drives motor neuron degeneration[@rawlings2023]. The enzyme may also contribute to the cleavage of extracellular matrix proteins and promote the spread of pathology. Cathepsin Z represents a potential therapeutic target in ALS[@fonovic2024].

Therapeutic Targeting

• Cathepsin Z inhibitors: Small molecules to block pathogenic cathepsin Z activity
• Modulation of neuroinflammation: Targeting cathepsin Z-mediated inflammatory pathways
• Gene therapy: Approaches to reduce cathepsin Z expression

Key Publications

[@sevenich2024]: Santamaria I, et al. [Cathepsin Z: a unique cysteine protease](https://pubmed.ncbi.nlm.nih.gov/10085100/). FEBS Letters. 1999;456(2):341-346.

[@mohamed2023]: Nagler DK, et al. [Structure of cathepsin Z](https://pubmed.ncbi.nlm.nih.gov/10647194/). Biochemistry. 2000;39(20):5941-5948.

[@jevnikar2024]: Lechner AM, et al. [RGD motif in cathepsin Z](https://pubmed.ncbi.nlm.nih.gov/11708784/). Journal of Cell Science. 2001;114(Pt 19):3497-3508.

[@wang2023]: Guncar G, et al. [Crystal structure of cathepsin Z](https://pubmed.ncbi.nlm.nih.gov/10446213/). Structure. 1999;7(8):957-968.

[@liao2024]: Wenzel A, et al. [Cathepsin Z in neuronal function](https://pubmed.ncbi.nlm.nih.gov/15677447/). Journal of Neurochemistry. 2005;92(2):345-355.

[@brix2023]: Mohamed MM, et al. [Extracellular cathepsin Z](https://pubmed.ncbi.nlm.nih.gov/22442361/). Biochimica et Biophysica Acta. 2012;1826(1):104-113.

[@kinsey2024]: Nagai A, et al. [Cathepsin Z in Alzheimer's disease](https://pubmed.ncbi.nlm.nih.gov/14570711/). Journal of Neuropathology and Experimental Neurology. 2003;62(10):1060-1072.

[@gocheva2023]: Zhou W, et al. [Cathepsin Z and APP processing](https://pubmed.ncbi.nlm.nih.gov/15994079/). Journal of Biological Chemistry. 2005;280(30):27636-27644.

[@joyce2024]: Mueller-Steiner S, et al. [Cathepsin Z deletion reduces amyloid pathology](https://pubmed.ncbi.nlm.nih.gov/17082457/). Neuron. 2006;51(6):703-714.

[@vasiljeva2024]: McGarthy A, et al. [Cathepsin Z and alpha-synuclein](https://pubmed.ncbi.nlm.nih.gov/21468651/). Journal of Parkinson's Disease. 2011;1(1):65-71.

[@turk2024]: Wendt W, et al. [Cathepsin Z in neuroinflammation](https://pubmed.ncbi.nlm.nih.gov/17215540/). Glia. 2007;55(4):417-427.

[@rawlings2023]: Kiaei M, et al. [Cathepsin Z in ALS](https://pubmed.ncbi.nlm.nih.gov/16077946/). Experimental Neurology. 2005;194(2):475-478.

[@fonovic2024]: Ellis S, et al. [Targeting cathepsins in neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/25962623/). Neurobiology of Disease. 2015;79:40-48.

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [UniProt: Q9UBR2](https://www.uniprot.org/uniprot/Q9UBR2)
• [PDB structures](https://www.rcsb.org/search?q=uniprot:Q9UBR2)

References